Vaikom Mahadevan, MD, FACC
Professor of Medicine
Structural Cardiology Specialist
Director, Adult Congenital Heart Disease (ACHD) Intervention Program
Dr. Vaikom Mahadevan is a world-renowned expert in interventional cardiology for treating adult congenital heart disease (ACHD) and structural heart disease. He has extensive experience in performing adult congenital and transcatheter valve procedures, including replacing all four of the heart's valves. He also has a strong interest in intracardiac echocardiography (ultrasound imaging inside the heart). He serves as director of the Adult Congenital Heart Disease and Structural Heart Intervention programs.
Mahadevan's research interests include transcatheter valve implantation and pulmonary hypertension in ACHD.
Mahadevan earned his medical degree from Stanley Medical College in Chennai, India, and received further training in internal medicine and cardiology in the United Kingdom. He completed a fellowship in adult congenital heart disease and intervention at the Royal Brompton Hospital in London, followed by a fellowship in the same specialties at Toronto General Hospital.
Before joining UCSF, Mahadevan served as a cardiology consultant and interventionist at the Manchester Royal Infirmary, part of Central Manchester University Hospitals. He was director of the ACHD and transcatheter aortic valve replacement program in Manchester, and he directed the ACHD interventional program for northwestern England. He also established and led the adult congenital pulmonary hypertension service for this region.
Recently, Dr. Mahadevan was selected to serve as a member of the NCDR IMPACT Registry Research & Publications Subcommittee, which is through the American College of Cardiology (ACC). Dr. Mahadevan is recognized as a leader in the College.
